The influence of psychiatric screening in healthy populations selection: a new study and meta-analysis of functional 5-HTTLPR and rs25531 polymorphisms and anxiety-related personality traits

BMC Psychiatry

Massimo Gennarelli¹  Riccardo Sartori³  Catia Scassellati²  Cristian Bonvicini²  Alessandra Minelli² 

[1] Department of Biomedical Sciences and Biotechnologies, Biology and Genetic Division, University School of Medicine, Brescia, Italy;Genetic Unit, I.R.C.C.S. "San Giovanni di Dio" - Fatebenefratelli, Brescia, Italy;Department of Philosophy, Pedagogy, Psychology, University of Verona, Verona, Italy

关键词: meta-analysis;    rs25531;    5-HTTLPR;    Harm Avoidance;    Neuroticism;   

Others  :  1124586
DOI  :  10.1186/1471-244X-11-50

 received in 2010-08-04, accepted in 2011-03-31,  发布年份 2011

【 摘 要 】

Background

A genetic liability for anxiety-related personality traits in healthy subjects has been associated with the functional serotonin transporter promoter polymorphism (5-HTTLPR), although the data are somewhat conflicting. Moreover, only one study has investigated the functional significance of the 5-HTTLPR/rs25531 haplotypes in relation to anxiety traits in healthy subjects. We tested whether the 5-HTTLPR polymorphism and the 5-HTTLPR/rs25531 haplotypes are linked to Harm Avoidance (HA) using an association study (STUDY I) and a meta-analytic approach (STUDY II).

Methods

STUDY I: A total of 287 unrelated Italian volunteers were screened for DSM-IV Axis I disorders and genotyped for the 5-HTTLPR and rs25531 (A/G) polymorphisms. Different functional haplotype combinations were also analyzed. STUDY II: A total of 44 studies were chosen for a meta-analysis of the putative association between 5-HTTLPR and anxiety-related personality traits.

Results

STUDY I: In the whole sample of 287 volunteers, we found that the SS genotype and S'S' haplotypes were associated with higher scores on HA. However, because the screening assessed by Mini-International Neuropsychiatric Interview (M.I.N.I.) showed the presence of 55 volunteers affected by depression or anxiety disorders, we analyzed the two groups ("disordered" and "healthy") separately. The data obtained did indeed confirm that in the "healthy" group, the significant effects of the SS genotype and S'S' haplotypes were lost, but they remained in the "disordered" group. STUDY II: The results of the 5-HTTLPR meta-analysis with anxiety-related traits in the whole sample confirmed the association of the SS genotype with higher anxiety-related traits scores in Caucasoids; however, when we analyzed only those studies that used structured psychiatric screening, no association was found.

Conclusions

This study demonstrates the relevance to perform analyses on personality traits only in DSM-IV axis I disorder-free subjects. Furthermore, we did not find an association between functional serotonin transporter gene polymorphisms and anxiety traits in healthy subjects screened through a structured psychiatric interview.

【 授权许可】

   
2011 Minelli et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Bouchard TJ Jr, Loehlin JC: Genes, evolution, and personality. Behav Genet 2001, 31(3):243-273.
• [2]Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP: Allelic variation of human serotonin transporter gene expression. J Neurochem 1996, 66(6):2621-2624.
• [3]Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL: Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274(5292):1527-1531.
• [4]Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, et al.: Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 2006, 78(5):815-826.
• [5]Zandi PP, Judy JT: The promise and reality of pharmacogenetics in psychiatry. Clin Lab Med 30(4):931-974.
• [6]Serretti A, Kato M, De Ronchi D, Kinoshita T: Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry 2007, 12(3):247-257.
• [7]Horstmann S, Binder EB: Pharmacogenomics of antidepressant drugs. Pharmacol Ther 2009, 124(1):57-73.
• [8]Bonvicini C, Minelli A, Scassellati C, Bortolomasi M, Segala M, Sartori R, Giacopuzzi M, Gennarelli M: Serotonin transporter gene polymorphisms and treatment-resistant depression. Prog Neuropsychopharmacol Biol Psychiatry 34(6):934-939.
• [9]Uher R, McGuffin P: The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Mol Psychiatry 15(1):18-22.
• [10]Wankerl M, Wust S, Otte C: Current developments and controversies: does the serotonin transporter gene-linked polymorphic region (5-HTTLPR) modulate the association between stress and depression? Curr Opin Psychiatry 23(6):582-587.
• [11]Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE: Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 167(5):509-527.
• [12]Lipsky RH, Hu XZ, Goldman D: Additional functional variation at the SLC6A4 gene. Am J Med Genet B Neuropsychiatr Genet 2009, 150B(1):153.
• [13]Wendland JR, Moya PR, Kruse MR, Ren-Patterson RF, Jensen CL, Timpano KR, Murphy DL: A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder. Hum Mol Genet 2008, 17(5):717-723.
• [14]Martin J, Cleak J, Willis-Owen SA, Flint J, Shifman S: Mapping regulatory variants for the serotonin transporter gene based on allelic expression imbalance. Mol Psychiatry 2007, 12(5):421-422.
• [15]Costa PT Jr, McCrae RR: Revised NEO personality inventory (NEO-PI-R) and NEO five-factor inventory (NEO-FFI) professional manual. Odessa, FL: Psychological Assessment Resources; 1992.
• [16]Cloninger CR, Svrakic DM, Przybeck TR: A psychobiological model of temperament and character. Arch Gen Psychiatry 1993, 50(12):975-990.
• [17]Zuckerman M, Cloninger CR: Relationships between Cloninger's, Zuckerman's, and Eysenck's dimension of personality. Pers Individ Differ 1996, 21(2):283-285.
• [18]Sher KJ, Bartholow BD, Wood MD: Personality and substance use disorders: a prospective study. J Consult Clin Psychol 2000, 68(5):818-829.
• [19]De Fruyt F, De Clercq BJ, van de Wiele L, Van Heeringen K: The validity of Cloninger's psychobiological model versus the five-factor model to predict DSM-IV personality disorders in a heterogeneous psychiatric sample: domain facet and residualized facet descriptions. J Pers 2006, 74(2):479-510.
• [20]Munafo MR, Clark TG, Moore LR, Payne E, Walton R, Flint J: Genetic polymorphisms and personality in healthy adults: a systematic review and meta-analysis. Mol Psychiatry 2003, 8(5):471-484.
• [21]Munafo MR, Clark T, Flint J: Does measurement instrument moderate the association between the serotonin transporter gene and anxiety-related personality traits? A meta-analysis. Mol Psychiatry 2005, 10(4):415-419.
• [22]Munafo MR, Freimer NB, Ng W, Ophoff R, Veijola J, Miettunen J, Jarvelin MR, Taanila A, Flint J: 5-HTTLPR genotype and anxiety-related personality traits: a meta-analysis and new data. Am J Med Genet B Neuropsychiatr Genet 2009, 150B(2):271-281.
• [23]Schinka JA, Busch RM, Robichaux-Keene N: A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol Psychiatry 2004, 9(2):197-202.
• [24]Sen S, Burmeister M, Ghosh D: Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet 2004, 127B(1):85-89.
• [25]Smith DJ, Duffy L, Stewart ME, Muir WJ, Blackwood DH: High harm avoidance and low self-directedness in euthymic young adults with recurrent, early-onset depression. J Affect Disord 2005, 87(1):83-89.
• [26]Matsudaira T, Kitamura T: Personality traits as risk factors of depression and anxiety among Japanese students. J Clin Psychol 2006, 62(1):97-109.
• [27]Jylha P, Isometsa E: Temperament, character and symptoms of anxiety and depression in the general population. Eur Psychiatry 2006, 21(6):389-395.
• [28]de Winter RF, Wolterbeek R, Spinhoven P, Zitman FG, Goekoop JG: Character and temperament in major depressive disorder and a highly anxious-retarded subtype derived from melancholia. Compr Psychiatry 2007, 48(5):426-435.
• [29]Holsboer F: How can we realize the promise of personalized antidepressant medicines? Nat Rev Neurosci 2008, 9(8):638-646.
• [30]Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(Suppl 20):22-33. quiz 34-57
• [31]Martinotti G, Mandelli L, Di Nicola M, Serretti A, Fossati A, Borroni S, Cloninger CR, Janiri L: Psychometric characteristic of the Italian version of the Temperament and Character Inventory--revised, personality, psychopathology, and attachment styles. Compr Psychiatry 2008, 49(5):514-522.
• [32]Folstein MF, Folstein SE, McHugh PR: "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12(3):189-198.
• [33]Hirano S, Sato T, Narita T, Kusunoki K, Ozaki N, Kimura S, Takahashi T, Sakado K, Uehara T: Evaluating the state dependency of the Temperament and Character Inventory dimensions in patients with major depression: a methodological contribution. J Affect Disord 2002, 69(1-3):31-38.
• [34]Marijnissen G, Tuinier S, Sijben AE, Verhoeven WM: The temperament and character inventory in major depression. J Affect Disord 2002, 70(2):219-223.
• [35]Farmer A, Mahmood A, Redman K, Harris T, Sadler S, McGuffin P: A sib-pair study of the Temperament and Character Inventory scales in major depression. Arch Gen Psychiatry 2003, 60(5):490-496.
• [36]Abrams KY, Yune SK, Kim SJ, Jeon HJ, Han SJ, Hwang J, Sung YH, Lee KJ, Lyoo IK: Trait and state aspects of harm avoidance and its implication for treatment in major depressive disorder, dysthymic disorder, and depressive personality disorder. Psychiatry Clin Neurosci 2004, 58(3):240-248.
• [37]Strobel A, Brocke B, Ebstein RP: Interektionseffekte monoaminrelevanter genetischer polymorphismen mit traits des TPQ [Interaction effects of monoamine-relevant genetic polymorphisms with traits of the TPQ]. Z Different Diagnost Psychol 2000, 21:194-199.
• [38]Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. Bmj 2003, 327(7414):557-560.
• [39]DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-188.
• [40]Ebstein RP, Gritsenko I, Nemanov L, Frisch A, Osher Y, Belmaker RH: No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance. Mol Psychiatry 1997, 2(3):224-226.
• [41]Nakamura T, Muramatsu T, Ono Y, Matsushita S, Higuchi S, Mizushima H, Yoshimura K, Kanba S, Asai M: Serotonin transporter gene regulatory region polymorphism and anxiety-related traits in the Japanese. Am J Med Genet 1997, 74(5):544-545.
• [42]Mazzanti CM, Lappalainen J, Long JC, Bengel D, Naukkarinen H, Eggert M, Virkkunen M, Linnoila M, Goldman D: Role of the serotonin transporter promoter polymorphism in anxiety-related traits. Arch Gen Psychiatry 1998, 55(10):936-940.
• [43]Monteleone P, Santonastaso P, Mauri M, Bellodi L, Erzegovesi S, Fuschino A, Favaro A, Rotondo A, Castaldo E, Maj M: Investigation of the serotonin transporter regulatory region polymorphism in bulimia nervosa: relationships to harm avoidance, nutritional parameters, and psychiatric comorbidity. Psychosom Med 2006, 68(1):99-103.
• [44]Ricketts MH, Hamer RM, Sage JI, Manowitz P, Feng F, Menza MA: Association of a serotonin transporter gene promoter polymorphism with harm avoidance behaviour in an elderly population. Psychiatr Genet 1998, 8(2):41-44.
• [45]Flory JD, Manuck SB, Ferrell RE, Dent KM, Peters DG, Muldoon MF: Neuroticism is not associated with the serotonin transporter (5-HTTLPR) polymorphism. Mol Psychiatry 1999, 4(1):93-96.
• [46]Hamer DH, Greenberg BD, Sabol SZ, Murphy DL: Role of the serotonin transporter gene in temperament and character. J Pers Disord 1999, 13(4):312-327.
• [47]Katsuragi S, Kunugi H, Sano A, Tsutsumi T, Isogawa K, Nanko S, Akiyoshi J: Association between serotonin transporter gene polymorphism and anxiety-related traits. Biol Psychiatry 1999, 45(3):368-370.
• [48]Kazantseva AV, Gaysina DA, Faskhutdinova GG, Noskova T, Malykh SB, Khusnutdinova EK: Polymorphisms of the serotonin transporter gene (5-HTTLPR, A/G SNP in 5-HTTLPR, and STin2 VNTR) and their relation to personality traits in healthy individuals from Russia. Psychiatr Genet 2008, 18(4):167-176.
• [49]Kumakiri C, Kodama K, Shimizu E, Yamanouchi N, Okada S, Noda S, Okamoto H, Sato T, Shirasawa H: Study of the association between the serotonin transporter gene regulatory region polymorphism and personality traits in a Japanese population. Neurosci Lett 1999, 263(2-3):205-207.
• [50]Benjamin J, Osher Y, Kotler M, Gritsenko I, Nemanov L, Belmaker RH, Ebstein RP: Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT). Mol Psychiatry 2000, 5(1):96-100.
• [51]Du L, Bakish D, Hrdina PD: Gender differences in association between serotonin transporter gene polymorphism and personality traits. Psychiatr Genet 2000, 10(4):159-164.
• [52]Greenberg BD, Li Q, Lucas FR, Hu S, Sirota LA, Benjamin J, Lesch KP, Hamer D, Murphy DL: Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am J Med Genet 2000, 96(2):202-216.
• [53]Herbst JH, Zonderman AB, McCrae RR, Costa PT Jr: Do the dimensions of the temperament and character inventory map a simple genetic architecture? Evidence from molecular genetics and factor analysis. Am J Psychiatry 2000, 157(8):1285-1290.
• [54]Hu S, Brody CL, Fisher C, Gunzerath L, Nelson ML, Sabol SZ, Sirota LA, Marcus SE, Greenberg BD, Murphy DL, et al.: Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior. Mol Psychiatry 2000, 5(2):181-188.
• [55]Osher Y, Hamer D, Benjamin J: Association and linkage of anxiety-related traits with a functional polymorphism of the serotonin transporter gene regulatory region in Israeli sibling pairs. Mol Psychiatry 2000, 5(2):216-219.
• [56]Schmidt NB, Storey J, Greenberg BD, Santiago HT, Li Q, Murphy DL: Evaluating gene × psychological risk factor effects in the pathogenesis of anxiety: a new model approach. J Abnorm Psychol 2000, 109(2):308-320.
• [57]Samochowiec J, Rybakowski F, Czerski P, Zakrzewska M, Stepien G, Pelka-Wysiecka J, Horodnicki J, Rybakowski JK, Hauser J: Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationship to temperamental dimensions measured by the Temperament and Character Inventory in healthy volunteers. Neuropsychobiology 2001, 43(4):248-253.
• [58]Tsai SJ, Hong CJ, Cheng CY: Serotonin transporter genetic polymorphisms and harm avoidance in the Chinese. Psychiatr Genet 2002, 12(3):165-168.
• [59]Samochowiec J, Syrek S, Michal P, Ryzewska-Wodecka A, Samochowiec A, Horodnicki J, Zakrzewska M, Kucharska-Mazur J: Polymorphisms in the serotonin transporter and monoamine oxidase A genes and their relationship to personality traits measured by the Temperament and Character Inventory and NEO Five-Factor Inventory in healthy volunteers. Neuropsychobiology 2004, 50(2):174-181.
• [60]Sen S, Villafuerte S, Nesse R, Stoltenberg SF, Hopcian J, Gleiberman L, Weder A, Burmeister M: Serotonin transporter and GABAA alpha 6 receptor variants are associated with neuroticism. Biol Psychiatry 2004, 55(3):244-249.
• [61]Szekely A, Ronai Z, Nemoda Z, Kolmann G, Gervai J, Sasvari-Szekely M: Human personality dimensions of persistence and harm avoidance associated with DRD4 and 5-HTTLPR polymorphisms. Am J Med Genet B Neuropsychiatr Genet 2004, 126B(1):106-110.
• [62]Thierry N, Willeit M, Praschak-Rieder N, Zill P, Hornik K, Neumeister A, Lenzinger E, Stastny J, Hilger E, Konstantinidis A, et al.: Serotonin transporter promoter gene polymorphic region (5-HTTLPR) and personality in female patients with seasonal affective disorder and in healthy controls. Eur Neuropsychopharmacol 2004, 14(1):53-58.
• [63]Park JW, Kim JS, Lee HK, Kim YI, Lee KS: Serotonin transporter polymorphism and harm avoidance personality in chronic tension-type headache. Headache 2004, 44(10):1005-1009.
• [64]Umekage T, Tochigi M, Marui T, Kato C, Hibino H, Otani T, Kohda K, Kato N, Sasaki T: Serotonin transporter-linked promoter region polymorphism and personality traits in a Japanese population. Neurosci Lett 2003, 337(1):13-16.
• [65]Lanzagorta N, Alexanderson-Rosas E, Ricalde A, Gomez Caudillo L, Sosa A, Camarena B, Aguilar A, Fresan A, Apiquian R, Nicolini H: [Effect to the serotonin transporter gene (5-HTT) on personality dimensions in individuals without psychopathology]. Actas Esp Psiquiatr 2006, 34(5):303-308.
• [66]Lang UE, Bajbouj M, Wernicke C, Rommelspacher H, Danker-Hopfe H, Gallinat J: No association of a functional polymorphism in the serotonin transporter gene promoter and anxiety-related personality traits. Neuropsychobiology 2004, 49(4):182-184.
• [67]Kim SJ, Kim YS, Choi NK, Hong HJ, Lee HS, Kim CH: Serotonin transporter gene polymorphism and personality traits in a Korean population. Neuropsychobiology 2005, 51(4):243-247.
• [68]Kremer I, Bachner-Melman R, Reshef A, Broude L, Nemanov L, Gritsenko I, Heresco-Levy U, Elizur Y, Ebstein RP: Association of the serotonin transporter gene with smoking behavior. Am J Psychiatry 2005, 162(5):924-930.
• [69]Jacob CP, Strobel A, Hohenberger K, Ringel T, Gutknecht L, Reif A, Brocke B, Lesch KP: Association between allelic variation of serotonin transporter function and neuroticism in anxious cluster C personality disorders. Am J Psychiatry 2004, 161(3):569-572.
• [70]Ham BJ, Kim YH, Choi MJ, Cha JH, Choi YK, Lee MS: Serotonergic genes and personality traits in the Korean population. Neurosci Lett 2004, 354(1):2-5.
• [71]Hariri AR, Drabant EM, Munoz KE, Kolachana BS, Mattay VS, Egan MF, Weinberger DR: A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry 2005, 62(2):146-152.
• [72]Dragan WL, Oniszczenko W: Association of a functional polymorphism in the serotonin transporter gene with personality traits in females in a Polish population. Neuropsychobiology 2006, 54(1):45-50.
• [73]Brummett BH, Siegler IC, McQuoid DR, Svenson IK, Marchuk DA, Steffens DC: Associations among the NEO Personality Inventory, Revised and the serotonin transporter gene-linked polymorphic region in elders: effects of depression and gender. Psychiatr Genet 2003, 13(1):13-18.
• [74]Cohen H, Buskila D, Neumann L, Ebstein RP: Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5-HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis Rheum 2002, 46(3):845-847.
• [75]Gonda X, Fountoulakis KN, Juhasz G, Rihmer Z, Lazary J, Laszik A, Akiskal HS, Bagdy G: Association of the s allele of the 5-HTTLPR with neuroticism-related traits and temperaments in a psychiatrically healthy population. Eur Arch Psychiatry Clin Neurosci 2009, 259(2):106-113.
• [76]Lee YS, Han DH, Yang KC, Daniels MA, Na C, Kee BS, Renshaw PF: Depression like characteristics of 5HTTLPR polymorphism and temperament in excessive internet users. J Affect Disord 2008, 109(1-2):165-169.
• [77]Joo YH, Oh HB, Kim B, Jung SH, Chung JK, Hong JP, Kim CY: No association between 5-HTTLPR and harm avoidance in Korean college students. J Korean Med Sci 2007, 22(1):138-141.
• [78]Hunnerkopf R, Strobel A, Gutknecht L, Brocke B, Lesch KP: Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits. Neuropsychopharmacology 2007, 32(12):2552-2560.
• [79]Nilsson KW, Damberg M, Ohrvik J, Leppert J, Lindstrom L, Anckarsater H, Oreland L: Genes encoding for AP-2beta and the Serotonin Transporter are associated with the Personality Character Spiritual Acceptance. Neurosci Lett 2007, 411(3):233-237.
• [80]Serretti A, Mandelli L, Lorenzi C, Landoni S, Calati R, Insacco C, Cloninger CR: Temperament and character in mood disorders: influence of DRD4, SERTPR, TPH and MAO-A polymorphisms. Neuropsychobiology 2006, 53(1):9-16.
• [81]Stein MB, Schork NJ, Gelernter J: Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders. Neuropsychopharmacology 2008, 33(2):312-319.
• [82]Suzuki A, Matsumoto Y, Oshino S, Kamata M, Goto K, Otani K: Combination of the serotonin transporter and norepinephrine transporter gene promoter polymorphisms might influence harm avoidance and novelty seeking in healthy females. Neurosci Lett 2008, 439(1):52-55.
• [83]Terracciano A, Balaci L, Thayer J, Scally M, Kokinos S, Ferrucci L, Tanaka T, Zonderman AB, Sanna S, Olla N, et al.: Variants of the serotonin transporter gene and NEO-PI-R Neuroticism: No association in the BLSA and SardiNIA samples. Am J Med Genet B Neuropsychiatr Genet 2009.
• [84]Vormfelde SV, Hoell I, Tzvetkov M, Jamrozinski K, Sehrt D, Brockmoller J, Leibing E: Anxiety- and novelty seeking-related personality traits and serotonin transporter gene polymorphisms. J Psychiatr Res 2006, 40(6):568-576.
• [85]Schmitz A, Hennig J, Kuepper Y, Reuter M: The association between neuroticism and the serotonin tranporter polymorphism depends on structural differences between personality measures. Pers Individ Differ 2007, 42(4):789-799.
• [86]Bachner-Melman R, Dina C, Zohar AH, Constantini N, Lerer E, Hoch S, Sella S, Nemanov L, Gritsenko I, Lichtenberg P, et al.: AVPR1a and SLC6A4 gene polymorphisms are associated with creative dance performance. PLoS Genet 2005, 1(3):e42.
• [87]Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H, Mann MB, Dietz G, Saucier G, MacMurray JP: A multivariate analysis of 59 candidate genes in personality traits: the temperament and character inventory. Clin Genet 2000, 58(5):375-385.
• [88]Saiz PA, Garcia-Portilla MP, Herrero R, Arango C, Corcoran P, Morales B, Bascaran MT, Alvarez V, Coto E, Paredes B, et al.: Interactions between functional serotonergic polymorphisms and demographic factors influence personality traits in healthy Spanish Caucasians. Psychiatr Genet
• [89]Minelli A, Pedrini L, Magni LR, Rotondo A: Personality traits in an italian sample: relationship with anxiety and depression. Clin Pract Epidemiol Ment Health 2009, 5:26-30.
• [90]Goldman N, Glei DA, Lin YH, Weinstein M: The serotonin transporter polymorphism (5-HTTLPR): allelic variation and links with depressive symptoms. Depress Anxiety 27(3):260-269.